A Study to Compare mRNA-1273 Versus BNT162b2 COVID-19 Vaccines Among Immunocompromised Adults
Clinical trial NCT05366322 · COMPLETED
Trial details
- NCT number
- NCT05366322
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-09-10
- Primary completion
- 2022-02-04
- Enrollment
- 124879
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.